We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

28 hedge funds and large institutions have $1.19M invested in PDS Biotechnology in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

33% more funds holding

Funds holding: 21 → 28 (+7)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

1.91% more ownership

Funds ownership: 9.36% → 11.27% (+1.9%)

17% less capital invested

Capital invested by funds: $1.43M → $1.19M (-$243K)

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$665K
2
Renaissance Technologies
Renaissance Technologies
New York
+$328K
3
WVP
Worth Venture Partners
New Jersey
+$281K
4
First Manhattan
First Manhattan
New York
+$258K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$131K

Top Sellers

Rank Fund Capital Flow
1
RC
RegentAtlantic Capital
New Jersey
-$42K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.64K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$2.34K
4
Bank of America
Bank of America
North Carolina
-$433
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$280K +$665K +384,000 New
Renaissance Technologies
2
Renaissance Technologies
New York
$226K +$328K +189,352 +157%
WVP
3
Worth Venture Partners
New Jersey
$118K +$281K +162,000 New
First Manhattan
4
First Manhattan
New York
$108K +$258K +149,067 New
SI
5
Sofinnova Investments
California
$104K – – –
NLVP
6
New Leaf Venture Partners
New York
$85K – – –
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$55K +$131K +75,342 New
Millennium Management
8
Millennium Management
New York
$49K +$116K +67,235 New
UBS Group
9
UBS Group
Switzerland
$28K +$57.1K +32,950 +605%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$26K +$63K +36,365 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$25K -$2.34K -1,352 -4%
IWA
12
Inspirion Wealth Advisors
Illinois
$17K +$866 +500 +2%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$13K – – –
AFM
14
Andesa Financial Management
Pennsylvania
$12K – – –
BlackRock
15
BlackRock
New York
$10K – – –
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$10K – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$9K -$2.64K -1,525 -11%
Northern Trust
18
Northern Trust
Illinois
$8K +$19.9K +11,463 New
Victory Capital Management
19
Victory Capital Management
Texas
$4K +$7.4K +4,272 New
EIP
20
Ellis Investment Partners
Pennsylvania
$1K – – –
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
$1 – – –
RC
22
RegentAtlantic Capital
New Jersey
– -$42K -15,753 Closed
Bank of America
23
Bank of America
North Carolina
– -$433 -250 -94%
Osaic Holdings
24
Osaic Holdings
Arizona
– +$19 +11 New
Wells Fargo
25
Wells Fargo
California
– +$126 +73 +3,650%
1
2

PDSB Hedge Fund Activity: Q1 2020 in Review

28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q1 2020, worth a combined $1.19M — down 17% from $1.43M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new PDSB positions and 2 closed out — a net gain of 8 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Federated Hermes, opening a new position worth an estimated $665K. The largest seller was RegentAtlantic Capital, exiting entirely with an estimated $42K sold.

  • 28 institutional investors held PDS Biotechnology (PDSB) as of Q1 2020, up from 21 in Q4 2019.
  • Funds reported $1.19M of PDS Biotechnology stock for Q1 2020, down 17% quarter-over-quarter.
  • 10 funds opened new PDS Biotechnology positions in Q1 2020 and 2 closed out, a net change of +8 holders.
  • The largest PDS Biotechnology buyer in Q1 2020 was Federated Hermes, an estimated $665K added.
  • The largest PDS Biotechnology seller in Q1 2020 was RegentAtlantic Capital, an estimated $42K sold.

Based on aggregated 13F filings for Q1 2020.